Mezzion Pharma announces the presentation of the FUEL Trial data at the American Heart Association Meeting in Philadelphia

DEERFIELD, Ill., Nov. 17, 2019 /PRNewswire/ -- Mezzion Pharma Co. Ltd. (140410: KOSDAQ) today announces the presentation of data from its pivotal clinical trial for its new orphan drug for the treatment of adolescents with single ventricle heart disease. Dr. David Goldberg, Pediatric...